Successful immune reconstitution decreases leukemic relapse and improves survival in recipients of unrelated cord blood transplantation - PubMed (original) (raw)
Clinical Trial
Successful immune reconstitution decreases leukemic relapse and improves survival in recipients of unrelated cord blood transplantation
Robertson Parkman et al. Biol Blood Marrow Transplant. 2006 Sep.
Free article
Abstract
Allogeneic hematopoietic stem cell transplantation (HSCT) is established therapy for selected patients with acute leukemia. After transplantation, antileukemic immune responses are believed to eliminate residual leukemia cells and decrease the likelihood of relapse. However, the clinical effect of successful antigen-specific immune reconstitution after HSCT on the likelihood of leukemic relapse and overall survival is not known. Pediatric recipients of unrelated cord blood transplants who underwent transplantation for acute leukemia were sequentially evaluated for their development of antigen-specific T-lymphocyte immunity to herpes viruses. The clinical effect of a positive antigen-specific response on relapse-free survival was determined. The presence of an antigen-specific response resulted in a relapse-free survival advantage (P = .0001), which was primarily due to a decrease in leukemic relapse (P = .003). Proportional hazards modeling for time to relapse and time to relapse or death defined 3 variables that were strongly associated with a poor outcome: female gender, poor remission status before transplantation, and negative antigen-specific T-lymphocyte proliferation. Notably neither acute nor chronic graft-versus-host disease had any effect on the incidence of leukemic relapse. Successful antigen-specific immune reconstitution after unrelated cord blood transplantation results in decreased leukemic relapse and improved overall survival.
Similar articles
- Long term disease-free survival in acute leukemia patients recovering with increased gammadelta T cells after partially mismatched related donor bone marrow transplantation.
Godder KT, Henslee-Downey PJ, Mehta J, Park BS, Chiang KY, Abhyankar S, Lamb LS. Godder KT, et al. Bone Marrow Transplant. 2007 Jun;39(12):751-7. doi: 10.1038/sj.bmt.1705650. Epub 2007 Apr 23. Bone Marrow Transplant. 2007. PMID: 17450185 Clinical Trial. - Early lymphocyte recovery after allogeneic hematopoietic SCT is associated with significant GVL effect in pediatric ALL but not acute myelogenous leukemia-Update study.
Afzal S, Ishaqi MK, Dupuis A, Doyle J, Gassas A. Afzal S, et al. Bone Marrow Transplant. 2009 Dec;44(12):799-804. doi: 10.1038/bmt.2009.91. Epub 2009 May 4. Bone Marrow Transplant. 2009. PMID: 19421173 Clinical Trial. - Unrelated donor allogeneic transplantation for adult acute lymphoblastic leukemia: a review.
Bachanova V, Weisdorf D. Bachanova V, et al. Bone Marrow Transplant. 2008 Mar;41(5):455-64. doi: 10.1038/sj.bmt.1705889. Epub 2007 Oct 29. Bone Marrow Transplant. 2008. PMID: 17968329 Review. - Allogeneic stem cell transplantation in acute myeloid leukemia: a risk-adapted approach.
Lodewyck T, Cornelissen JJ. Lodewyck T, et al. Blood Rev. 2008 Nov;22(6):293-302. doi: 10.1016/j.blre.2008.03.008. Epub 2008 May 1. Blood Rev. 2008. PMID: 18455284 Review.
Cited by
- Effects of Soy-Whey Protein Nutritional Supplementation on Hematopoiesis and Immune Reconstitution in an Allogeneic Transplanted Mice.
Wu X, Hou Q, Zhao Z, Wang J, Guo Y, Lu L, Han J. Wu X, et al. Nutrients. 2022 Jul 22;14(15):3014. doi: 10.3390/nu14153014. Nutrients. 2022. PMID: 35893870 Free PMC article. - Immune Reconstitution After Allogeneic Haematopoietic Cell Transplantation: From Observational Studies to Targeted Interventions.
Yanir A, Schulz A, Lawitschka A, Nierkens S, Eyrich M. Yanir A, et al. Front Pediatr. 2022 Jan 11;9:786017. doi: 10.3389/fped.2021.786017. eCollection 2021. Front Pediatr. 2022. PMID: 35087775 Free PMC article. Review. - Impact of CMV reactivation on relapse of acute myeloid leukemia after HCT is dependent on disease stage and ATG.
Turki AT, Tsachakis-Mück N, Leserer S, Crivello P, Liebregts T, Betke L, Alashkar F, Leimkühler NB, Trilling M, Fleischhauer K, Beelen DW. Turki AT, et al. Blood Adv. 2022 Jan 11;6(1):28-36. doi: 10.1182/bloodadvances.2021005509. Blood Adv. 2022. PMID: 34619756 Free PMC article. - [Correlation between immune reconstitution and chronic graft-versus-host disease after unrelated cord blood transplantation and sibling peripheral blood stem cell transplantation].
Wang J, Pan TZ, Huang PP, Sun ZM, Zhu HP. Wang J, et al. Zhonghua Xue Ye Xue Za Zhi. 2021 Jun 14;42(6):466-473. doi: 10.3760/cma.j.issn.0253-2727.2021.06.005. Zhonghua Xue Ye Xue Za Zhi. 2021. PMID: 34384152 Free PMC article. Chinese. - Associations between the Gut Microbiota, Immune Reconstitution, and Outcomes of Allogeneic Hematopoietic Stem Cell Transplantation.
Fiorenza S, Turtle CJ. Fiorenza S, et al. Immunometabolism. 2021;3(1):e210004. doi: 10.20900/immunometab20210004. Epub 2021 Jan 12. Immunometabolism. 2021. PMID: 33552594 Free PMC article.
Publication types
MeSH terms
Grants and funding
- N01-HB-67113/HB/NHLBI NIH HHS/United States
- N01-HB-67132/HB/NHLBI NIH HHS/United States
- N01-HB-67135/HB/NHLBI NIH HHS/United States
- N01-HB-67138/HB/NHLBI NIH HHS/United States
- N01-HB-67139/HB/NHLBI NIH HHS/United States
- P01-CA100265/CA/NCI NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical